Genetics of thyroid-associated ophthalmopathy: A play in search of a cast of characters

Journal of Endocrinological Investigation

Volumn 26, Issue 6, 2003, Pages 570-574

  Farid, N R ^a   Marga, M ^b  

^a Osancor Biotech Inc   (United Kingdom)

^b PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

Author keywords

Genetics; Graves' disease; Linkage association; Multifactorial; Thyroid associated ophthalmopathy

Indexed keywords

ANTIRETROVIRUS AGENT; ANTITHYROID AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

AUTOIMMUNE DISEASE; CHROMOSOME; CROHN DISEASE; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; ENTERITIS; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETICS; GRAVES DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHYROIDISM; MAJOR HISTOCOMPATIBILITY COMPLEX; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHENOTYPE; REVIEW; THYROID GLAND;

EID: 0042024950     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345223     Document Type: Review

References (14)

1. Farid N.R., and Balazs C. The genetics of thyroid associated opthalmopathy. Thyroid 1998, 5: 407-409.
2. Todd J.A. Human genetics. Tackling common disease. Nature 2001, 411: 537-539.
3. Podolsky D.K. Inflammatory bowel disease. N. Eng. J. Med. 2002, 347: 417-429.
4. Burghes A.H.M., Vaessin H.E.F., De La Chapelle A. The land between Menedelian and multifactorial inheritance. Science 2001, 293: 2213-2214.
5. Stenzsky V., Kozma L., Balazs C., Rochltiz S., Bear J.C., Farid N.R. The genetics of Graves' disease: HLA and disease susceptibility J. Clin. Endocrinol. Metab. 1985, 61: 735-740.
6. Ban Y., Davies T.F., Greenberg D.A., Concepcion E.S., Tomer Y. Potential role of HLA-DR-74 Arginine in the genetic susceptibility to Graves' disease. Program of the 84th Annual Meeting of the Endocrine Society, San Francisco, Cal., June 19-22, 2002, Abstract OR22-5.
7. Marga M., Denisova A., Sochnev A., Pirags V., Farid N.R. Two HLA-DRB1 alleles confer independent genetic susceptibility to Graves' disease: Relevance of cross-population studies. Am. J. Med. Genet. 2001, 102: 188-191.
8. Nelson J.L. Microchimerism: Incidental by-product of pregnancy or active participant in human health? Trends Mol. Med. 2002, 8: 109-113.
9. Tomer Y., Greenberg D.A., Concepcion E.S., Davies T.F. Genetic studies in a cohort of 102 multiplex autoimmune thyroid disease families with 540 individuals Program of the 84th Annual Meeting of the Endocrine Society, San Francisco, Cal., June 19-22, 2002, Abstract OR22-3
10. Frecker M., Stensky V., Balazs C., Kozma L., Kraszits E., Farid N.R. Genetic factors in Graves' disease. Clin. Endocrinol. (Oxf.) 1986, 25: 479-484.
11. Ludgate M., Baker G. Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin. Exp. Immunol. 2002, 127: 193-198.
12. Heufelder A.E. Pathogenesis of opthalmopathy in autoimmune thyroid disease. Rev. Endocr. Metab. Disord. 2000, 1: 87-95.
13. Valyasevi R.W., Harteneck D.A., Dutton C.M., Bahn R.S. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ) and the thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts. J. Clin. Endocrinol. Metab. 2002, 87: 2352-2358.
14. Koumas L., Smith T.J., Phipps R.P. Fibroblast subsets in the human orbit: Thy-1+ and Thy-1-subpopulations exhibit distinct phenotypes. Eur. J. Immunol. 2002, 32: 477-485.